Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure

Current Medical Research and Opinion

Volumn 17, Issue 4, 2001, Pages 290-297

  Anthopoulos, L ^a   Apostolou, T ^a   Bonoris, P ^a   Foussas, S ^a   Lefkos, N ^a   Zombolos, S ^a  

^a ATHENS MEDICAL CENTER   (Greece)

Author keywords

ACE inhibitors; Captopril; Chronic heart failure; First dose; Hypotension; Perindopril

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG TOLERABILITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOTENSION; MALE; PERINDOPRIL; RISK FACTORS;

EID: 0035713528     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079901753403199     Document Type: Article

References (41)

1. Pharmacologic treatment of congestive heart failure
2. Heart failure, ventricular remodelling and the reninangiotensin system: Insights from recently completed clinical trials
3. Therapy of left ventricular dysfunction: Implications of recent therapeutic trials and future directions for therapy
4. Guidelines for the evaluation and management of Heart Failure. ACC/AHA task force report
5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
6. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
7. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure
8. Effect of captopril on mortality and morbidity in patients with LVD after myocardial infarction. Results of the survival and ventricular enlargement trial
9. Tolerance to ACE inhibitors after cardiac surgery
10. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing
11. Underutilization of ACE inhibitors in heart failure
12. Angiotensin-converting enzyme inhibitors in heart failure: Target dose prescription in elderly patients
13. Failure to practice evidence-based medicine: Why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
14. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995
15. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure
16. Factors determining angiotensin-converting enzyme inhibitor utilization in heart failure in a community setting
17. First dose hypotension with enalapril and prazosin in congestive heart failure
18. Severe hypotension after first dose of enalapril in heart failure
19. A placebo-controlled trial of captopril in refractory chronic congestive heart failure
20. Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure - Acute and chronic hemodynamic evaluations
21. Comparison of captopril and enalapril in patients with severe chronic heart failure
22. Guidelines for the diagnosis and treatment of chronic heart failure
23. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1)
24. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
25. First-dose blood pressure response in mild-to-moderate heart failure: A randomised double-blind study comparing enalapril with lisinopril by 24-h non-invasive blood pressure monitoring
26. Hemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure
27. Differences in first-dose response to angiotensin-converting enzyme inhibition in congestive heart failure: A placebo controlled study
28. Angiotensin-converting enzyme inhibitors in heart failure: Blood pressure changes after the first dose
29. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure
30. Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril
31. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: A Malaysian experience
32. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: A comparison of enalapril and perindopril
33. Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors
34. Characterization of the effects of prodrug concentration on the in vitro potency of the metabolites of the five ACE inhibitors
35. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
36. Hypotension in patients with coronary disease: Can profound hypotensive events cause myocardial ischaemic events?
37. Coronary artery slow flow associated with angina pectoris and hypotension: A case report
38. Cerebral hemodynamics during cerebral ischemia induced by acute hypotension
39. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders
40. Twenty four hours BP control. Which is best trough: Peak ratios or ABPM?